DeltaNp63 expression is associated with poor survival in ovarian cancer.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Annals of Oncology

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ANNONC/MDM519PMID 17998283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.

  2008cited by this paper
• The Roles of p63 in Cancer

  2007cited by this paper
• TAp63 and ΔNp63 in Cancer and Epidermal Development

  2007cited by this paper
• Transcriptional Programs Regulated by p63 in Normal Epithelium and Tumors

  2007cited by this paper
• TAp63 and DeltaNp63 in cancer and epidermal development.

  2007cited by this paper
• Hitting the Numbers: The Emerging Network of p63 Targets

  2007cited by this paper
• p63, Cellular Senescence and Tumor Development

  2007cited by this paper
• A dominant negative form of p63 inhibits apoptosis in a p53-independent manner.

  2006cited by this paper
• p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis.

  2006cited by this paper
• Clinical Relevance of Dominant-Negative p73 Isoforms for Responsiveness to Chemotherapy and Survival in Ovarian Cancer: Evidence for a Crucial p53-p73 Cross-talk In vivo

  2005cited by this paper
• The common and distinct target genes of the p53 family transcription factors

  2004cited by this paper
• p63 and p73 are not required for the development and p53-dependent apoptosis of T cells.

  2004cited by this paper
• p63 and p73: roles in development and tumor formation.

  2004cited by this paper
• Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo

  2004cited by this paper
• Chemosensitivity linked to p73 function.

  2003cited by this paper
• The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.

  2003cited by this paper
• The ΔNp63α Phosphoprotein Binds the p21 and 14-3-3σ Promoters In Vivo and Has Transcriptional Repressor Activity That Is Reduced by Hay-Wells Syndrome-Derived Mutations

  2003cited by this paper
• Functional regulation of p73 and p63: development and cancer.

  2003cited by this paper
• Significance of p63 amplification and overexpression in lung cancer development and prognosis.

  2003cited by this paper
• P63 expression in normal, hyperplastic and malignant breast tissues

  2002cited by this paper
• p53 leans on its siblings.

  2002cited by this paper
• p63 and p73 are required for p53-dependent apoptosis in response to DNA damage

  2002cited by this paper
• Taking Advantage of Basic Research: p63 Is a Reliable Myoepithelial and Stem Cell Marker

  2002cited by this paper
• ΔNp63 induces β-catenin nuclear accumulation and signaling

  2002cited by this paper
• DeltaNp63 induces beta-catenin nuclear accumulation and signaling.

  2002cited by this paper
• p63 expression profiles in human normal and tumor tissues.

  2002cited by this paper
• Differential expression of p63 isoforms in normal tissues and neoplastic cells

  2002cited by this paper
• Loss of p63 expression is associated with tumor progression in bladder cancer.

  2002cited by this paper
• From p63 to p53 across p73

  2001cited by this paper
• p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.

  2001cited by this paper
• p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes

  2001cited by this paper
• p63 is a prostate basal cell marker and is required for prostate development.

  2000cited by this paper
• AIS is an oncogene amplified in squamous cell carcinoma.

  2000cited by this paper
• Frequent alteration of p63 expression in human primary bladder carcinomas.

  2000cited by this paper
• Expression of the p53 homologue p63alpha and deltaNp63alpha in normal and neoplastic cells.

  2000cited by this paper
• The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

  1999cited by this paper
• Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis.

  1999cited by this paper
• The transcriptional activities of p53 and its homologue p51/p63: similarities and differences.

  1999cited by this paper
• p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

  1999cited by this paper
• Interaction of c-Abl and p73α and their collaboration to induce apoptosis

  1999cited by this paper
• p63 is a p53 homologue required for limb and epidermal morphogenesis

  1999cited by this paper
• p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.

  1998cited by this paper
• Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers.

  1998cited by this paper
• Cloning and functional analysis of human p51, which structurally and functionally resembles p53

  1998cited by this paper
• Cancer of the ovary.

  1993cited by this paper

• Dual functions of the ΔNp63-miR-141-3p-YAP1 regulatory axis in cervical cancer progression are dependent on histological subtype

  2025cites this paper
• The Role of p53 Mutations in Early and Late Response to Mitotic Aberrations

  2025cites this paper
• circTP63-N suppresses the proliferation and metastasis of nasopharyngeal carcinoma via engaging with HSP90AB1 to modulate the YAP1/Hippo signaling pathway

  2024cites this paper
• Dysregulation of delta Np63 alpha in squamous cell carcinoma and its therapeutic targeting.

  2023cites this paper
• Genetic analysis of polymorphism rs10937405 of TP63 gene in breast and ovarian cancer patients of North Indian Cohort

  2023cites this paper
• Novel Histopathological Biomarkers in Prostate Cancer: Implications and Perspectives

  2023cites this paper
• Predicting the radiosensitivity of HPV-negative oropharyngeal squamous cell carcinoma using miR-130b

  2021cites this paper
• An integrated microfluidic platform for detection of ovarian clear cell carcinoma mRNA biomarker FXYD2.

  2021cites this paper
• Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis

  2020cites this paper
• Spatiotemporal Regulation of ΔNp63 by TGFβ-Regulated miRNAs Is Essential for Cancer Metastasis

  2020cites this paper
• IL-1β Inflammatory Cytokine-Induced TP63 Isoform ∆NP63α Signaling Cascade Contributes to Cisplatin Resistance in Human Breast Cancer Cells

  2019cites this paper
• TRIM8 Blunts the Pro-proliferative Action of ΔNp63α in a p53 Wild-Type Background

  2019cites this paper
• The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies

  2019cites this paper
• The importance of p53 pathway genetics in inherited and somatic cancer genomes

  2016cites this paper
• ΔNp63 mediates cellular survival and metastasis in canine osteosarcoma

  2016cites this paper
• Expression Profile of MicroRNA-203 and its ΔNp63 Target in Cervical Carcinogenesis: Prospects for Cervical Cancer Screening.

  2016cites this paper
• ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer.

  2016influential citation
• The diverse oncogenic and tumour suppressor roles of p63 and p73 in cancer: a review by cancer site.

  2015cites this paper
• MINIMAL ADENOCARCINOMA IN PROSTATE NEEDLE BIOPSY TISSUE: IMMUNOHISTOCHEMICAL STUDY

  2015cites this paper
• A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.

  2014cites this paper
• p 63 is an alternative p 53 repressor in melanoma that confers chemoresistance and a poor prognosis

  2013cites this paper
• p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis

  2013cites this paper
• Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer.

  2013cites this paper
• Ratio disruption of the ∆133p53 and TAp53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma.

  2013cites this paper
• The Zinc Finger Gene ZIC2 Has Features of an Oncogene and Its Overexpression Correlates Strongly with the Clinical Course of Epithelial Ovarian Cancer

  2012cites this paper
• Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors

  2012cites this paper
• Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis.

  2012cites this paper
• EVALUATION OF MINIMAL PROSTATE CANCER IN NEEDLE BIOPSY SPECIMENS USING AMACR ( P 504 S ) , P 63 AND KI 67

  2012cites this paper
• A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma

  2012cites this paper
• Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.

  2011cites this paper
• p63 and p73 Isoform Expression in Non-small Cell Lung Cancer and Corresponding Morphological Normal Lung Tissue

  2011cites this paper
• p53 Family: Role of Protein Isoforms in Human Cancer

  2011cites this paper
• DeltaNp63alpha confers tumor cell resistance to cisplatin through the AKT1 transcriptional regulation.

  2011cites this paper
• An integrative genomic approach identifies p73 and p63 as activators of miR-200 microRNA family transcription

  2011cites this paper
• Role of p63 in cancer development.

  2011cites this paper
• Expression pattern of p63 and p73 isoforms in cervical carcinoma

  2010cites this paper
• Chemotherapy Trials for Colorectal Cancer in Advanced Disease: What’s the Current Hypothesis?

  2010cites this paper
• Induction of cell cycle arrest by the dual activity of TRIM 8 on p 53 and DNp 63

  2010cites this paper
• Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma.

  2010cites this paper
• NAD(P)H Quinone Oxidoreductase Protects TAp63γ from Proteasomal Degradation and Regulates TAp63γ-Dependent Growth Arrest

  2010cites this paper
• Association between the N-terminally truncated (DeltaN) p63alpha (DeltaNp63alpha) isoform and debulking status, VEGF expression and progression-free survival in previously untreated, advanced stage epithelial ovarian cancer: A Gynecologic Oncology Group study.

  2009cites this paper
• Aberrant Cytoplasmic Expression of p63 and Prostate Cancer Mortality

  2009cites this paper
• Analysis of Gene Expression in Early-Stage Ovarian Cancer

  2008cites this paper